NCT03369431View on ClinicalTrials.gov

Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

October 2, 2020

Study Completion Date

January 29, 2021

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

Vivomixx

Multi-strain probiotic containing 450 billion lyophilized bacterial cells per sachet belonging to 8 probiotic strains. The probiotic strains contained in the intervention are Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus delbrueckii subsp. bulgaricus.

DIETARY_SUPPLEMENT

Placebo

4.4 grams of maltose and silicon dioxide per sachet

Trial Locations (1)

WC1E 6DB

University College Hospital, London

All Listed Sponsors
lead

University College, London

OTHER

NCT03369431 - Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter